Key facts
- This page summarizes Robert Keith Warner's Form 4 filing for RxSight, Inc. (RXST).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 Jan 2024, 16:10.
Robert Keith Warner - 08 Jan 2024 Form 4 Insider Report for RxSight, Inc. (RXST)
- Reporting relationship
- Director
- Issuer ticker
- RXST
- Reported as of
- 08 Jan 2024
- Net transaction value
- -$1,013,894
- SEC form
- 4
- Accepted by SEC
- 09 Jan 2024, 16:10:58 UTC
- Prior SEC filing
- 12 Dec 2023
- Next SEC filing
- 31 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shelley Thunen, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Keith Warner filed Form 4 for RxSight, Inc. (RXST) on 09 Jan 2024.
Change
- Previous filing in this sequence was filed on 12 Dec 2023.
- Current net transaction value: -$1,013,894.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RXST
transaction
Common Stock
Sale
- Transaction value
- $700,389
- Shares
- -16,530
- Change %
- -70%
- Price
- $42.37
- Shares after
- 7,220
- Date
- 08 Jan 2024
- Ownership
- See footnote
- Footnotes
- F1, F2, F3
RXST
transaction
Common Stock
Sale
- Transaction value
- $313,505
- Shares
- -7,220
- Change %
- -100%
- Price
- $43.42
- Shares after
- 0
- Date
- 08 Jan 2024
- Ownership
- See footnote
- Footnotes
- F1, F3, F4
RXST
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 27,733
- Date
- 08 Jan 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 4 footnotes
Footnote F1
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on August 24, 2023 by the Reporting Person.
Footnote F2
Represents the weighted average share price of an aggregate total of 16,530 shares sold in the price range of $42.00 to $42.995 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F3
Shares held by the Cabo Living Trust, for which the Reporting Person serves as trustee.
Footnote F4
Represents the weighted average share price of an aggregate total of 7,220 shares sold in the price range of $43.085 to $43.98 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.